Tinkering with a viral ribonucleotide reductase

Trends in Biochemical Sciences

Volumn 34, Issue 1, 2009, Pages 25-32

  Lembo, David ^a   Brune, Wolfram ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; PROTEIN SUBUNIT; RECEPTOR INTERACTING PROTEIN 1; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

CATALYSIS; CYTOMEGALOVIRUS; ENZYME ACTIVITY; ENZYME SUBUNIT; HERPES VIRUS; INFLAMMATION; INNATE IMMUNITY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEIC ACID METABOLISM; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; DNA; EVOLUTION, MOLECULAR; HERPESVIRIDAE; INFLAMMATION; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUROMEGALOVIRUS; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEOTIDE REDUCTASES; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

DNA VIRUSES; HERPESVIRIDAE; MURID HERPESVIRUS 1;

EID: 58149279459     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2008.09.008     Document Type: Review

References (54)

1. Jacob F. Evolution and tinkering. Science 196 (1977) 1161-1166
2. Mack C., et al. Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3094-3099
3. Upton J.W., et al. Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J. Biol. Chem. 283 (2008) 16966-16970
4. Pellet P.E., and Roizman B. The family of Herpesviridae: a brief introduction. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 5th edn (2007), Lippincott Williams & Wilkins 2479-2499
5. Conner J., et al. Ribonucleotide reductase of herpesviruses. Rev. Med. Virol. 4 (1994) 25-34
6. Goldstein D.J., and Weller S.K. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J. Virol. 62 (1988) 196-205
7. Cameron J.M., et al. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J. Gen. Virol. 69 (1988) 2607-2612
8. Jacobson J.G., et al. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology 173 (1989) 276-283
9. de Wind N., et al. Ribonucleotide reductase-deficient mutants of pseudorabies virus are avirulent for pigs and induce partial protective immunity. J. Gen. Virol. 74 (1993) 351-359
10. Heineman T.C., and Cohen J.I. Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro. J. Virol. 68 (1994) 3317-3323
11. Ball A.L. Virus replication strategies. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 5th edn (2007), Lippincott Williams & Wilkins 119-139
12. Shackelton L.A., and Holmes E.C. The evolution of large DNA viruses: combining genomic information of viruses and their hosts. Trends Microbiol. 12 (2004) 458-465
13. McGeoch D.J., et al. Topics in herpesvirus genomics and evolution. Virus Res. 117 (2006) 90-104
14. Tenser R.B. The role of herpes simplex virus thymidine kinase expression in pathogenesis and latency. In: Becker Y., and Darai G. (Eds). Pathogenesis of Human Herpes Viruses Due to Specific Pathogenicity Genes (1994), Springer 68-86
15. Holzerlandt R., et al. Identification of new herpesvirus gene homologs in the human genome. Genome Res. 12 (2002) 1739-1748
16. Sun Y., and Conner J. The U28 ORF of human herpesvirus-7 does not encode a functional ribonucleotide reductase R1 subunit. J. Gen. Virol. 80 (1999) 2713-2718
17. Patrone M., et al. The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. J. Gen. Virol. 84 (2003) 3359-3370
18. Lembo D., et al. The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J. Virol. 78 (2004) 4278-4288
19. Caposio P., et al. Evidence that the human cytomegalovirus 46-kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts. Virology 325 (2004) 264-276
20. Chee M.S., et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154 (1990) 125-169
21. Rawlinson W.D., et al. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70 (1996) 8833-8849
22. Novotny J., et al. In silico structural and functional analysis of the human cytomegalovirus (HHV5) genome. J. Mol. Biol. 310 (2001) 1151-1166
23. Nordlund P., and Reichard P. Ribonucleotide reductases. Annu. Rev. Biochem. 75 (2006) 681-706
24. Willoughby K., et al. Sequences of the ribonucleotide reductase-encoding genes of felid herpesvirus 1 and molecular phylogenetic analysis. Virus Genes 15 (1997) 203-218
25. Landolfo S., et al. The human cytomegalovirus. Pharmacol. Ther. 98 (2003) 269-297
26. Bain M., and Sinclair J. The S phase of the cell cycle and its perturbation by human cytomegalovirus. Rev. Med. Virol. 17 (2007) 423-434
27. Sanchez V., and Spector D.H. Subversion of cell cycle regulatory pathways. Curr. Top. Microbiol. Immunol. 325 (2008) 243-262
28. Wiebusch L., et al. Cell cycle independent expression of immediate early gene 3 results in a G1 and G2 arrest in MCMV-infected cells. J. Virol. 82 (2008) 10188-10198
29. Brune W., et al. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 291 (2001) 303-305
30. Meylan E., and Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem. Sci. 30 (2005) 151-159
31. Festjens N., et al. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ. 14 (2007) 400-410
32. Meylan E., et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κ B activation. Nat. Immunol. 5 (2004) 503-507
33. Yamamoto M., et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169 (2002) 6668-6672
34. Kaiser W.J., and Offermann M.K. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J. Immunol. 174 (2005) 4942-4952
35. Hahn G., et al. The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J. Virol. 76 (2002) 9551-9555
36. Smith C.C., and Aurelian L. The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity. Virology 234 (1997) 235-242
37. Langelier Y., et al. The R1 subunit of herpes simplex virus ribonucleotide reductase is a good substrate for host cell protein kinases but is not itself a protein kinase. J. Biol. Chem. 273 (1998) 1435-1443
38. Chabaud S., et al. The R1 subunit of herpes simplex virus ribonucleotide reductase has chaperone-like activity similar to Hsp27. FEBS Lett. 545 (2003) 213-218
39. Langelier Y., et al. The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation. J. Gen. Virol. 83 (2002) 2779-2789
40. Perkins D., et al. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1. J. Virol. 77 (2003) 1292-1305
41. Perkins D., et al. Expression of herpes simplex virus type 2 protein ICP10 PK rescues neurons from apoptosis due to serum deprivation or genetic defects. Exp. Neurol. 174 (2002) 118-122
42. Golembewski E.K., et al. The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity. Exp. Neurol. 203 (2007) 381-393
43. Chabaud S., et al. The ribonucleotide reductase domain of the R1 subunit of herpes simplex virus type 2 ribonucleotide reductase is essential for R1 antiapoptotic function. J. Gen. Virol. 88 (2007) 384-394
44. Gober M.D., et al. Herpes simplex virus type 2 encodes a heat shock protein homologue with apoptosis regulatory functions. Front. Biosci. 10 (2005) 2788-2803
45. McGeoch D.J., et al. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 247 (1995) 443-458
46. Kelliher M.A., et al. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8 (1998) 297-303
47. Cusson-Hermance N., et al. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation. J. Biol. Chem. 280 (2005) 36560-36566
48. Balachandran S., et al. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432 (2004) 401-405
49. Michallet M.C., et al. TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28 (2008) 651-661
50. Janssens S., et al. PIDD mediates NF-κB activation in response to DNA damage. Cell 123 (2005) 1079-1092
51. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat. Immunol. 7 (2006) 131-137
52. Young P., et al. Intron-containing T4 bacteriophage gene sunY encodes an anaerobic ribonucleotide reductase. J. Biol. Chem. 269 (1994) 20229-20232
53. Hatfull G.F., and Sarkis G.J. DNA sequence, structure and gene expression of mycobacteriophage L5: a phage system for mycobacterial genetics. Mol. Microbiol. 7 (1993) 395-405
54. Tidona C.A., and Darai G. Iridovirus homologues of cellular genes-implications for the molecular evolution of large DNA viruses. Virus Genes 21 (2000) 77-81